Using a siRNA-based silencing approach, p70S6K siRNA significantly suppressed MCS formation, establishing that p70S6K as an endogenous promoter of MCS formation in ovarian cancer (Figure 1B). Here, RPS6KB1 is linked to ovarian cancer.